ID   I11RA_RAT               Reviewed;         431 AA.
AC   Q99MF4;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   24-JUL-2024, entry version 147.
DE   RecName: Full=Interleukin-11 receptor subunit alpha {ECO:0000305};
DE            Short=IL-11 receptor subunit alpha;
DE            Short=IL-11R subunit alpha;
DE            Short=IL-11R-alpha;
DE            Short=IL-11RA;
DE   Contains:
DE     RecName: Full=Soluble interleukin-11 receptor subunit alpha {ECO:0000305};
DE              Short=sIL-11R;
DE              Short=sIL-11RA;
DE              Short=sIL11RA {ECO:0000305};
DE   Flags: Precursor;
GN   Name=Il11ra1 {ECO:0000312|RGD:621332};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Li R., Hartley L., Robb L.;
RT   "Expression of interleukin-11 and interleukin-11 receptor alpha chain in
RT   the rat uterus in the peri-implantation period.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for interleukin-11 (IL11). The receptor systems for
CC       IL6, LIF, OSM, CNTF, IL11 and CT1 can utilize IL6ST for initiating
CC       signal transmission. The IL11/IL11RA/IL6ST complex may be involved in
CC       the control of proliferation and/or differentiation of skeletogenic
CC       progenitor or other mesenchymal cells. Essential for the normal
CC       development of craniofacial bones and teeth. Restricts suture fusion
CC       and tooth number. {ECO:0000250|UniProtKB:Q14626}.
CC   -!- FUNCTION: [Soluble interleukin-11 receptor subunit alpha]: Soluble form
CC       of IL11 receptor (sIL11RA) that acts as an agonist of IL11 activity.
CC       The IL11:sIL11RA complex binds to IL6ST/gp130 on cell surfaces and
CC       induces signaling also on cells that do not express membrane-bound
CC       IL11RA in a process called IL11 trans-signaling.
CC       {ECO:0000250|UniProtKB:Q14626}.
CC   -!- SUBUNIT: On IL11 binding, forms a multimer complex with IL6ST/gp130.
CC       {ECO:0000250|UniProtKB:Q14626}.
CC   -!- SUBCELLULAR LOCATION: [Interleukin-11 receptor subunit alpha]: Membrane
CC       {ECO:0000250|UniProtKB:Q14626}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Soluble interleukin-11 receptor subunit alpha]:
CC       Secreted {ECO:0000250|UniProtKB:Q14626}.
CC   -!- PTM: A short soluble form is also released from the membrane by
CC       proteolysis. The sIL11RA is formed either by limited proteolysis of
CC       membrane-bound receptors, a process referred to as ectodomain shedding,
CC       or directly secreted from the cells after alternative mRNA splicing.
CC       mIL11RA is cleaved by the proteases ADAM10, ELANE and PRTN3.
CC       {ECO:0000250|UniProtKB:Q14626}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 3
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF347936; AAK29624.1; -; mRNA.
DR   EMBL; BC070921; AAH70921.1; -; mRNA.
DR   RefSeq; NP_620816.1; NM_139116.1.
DR   RefSeq; XP_006238085.1; XM_006238023.3.
DR   AlphaFoldDB; Q99MF4; -.
DR   SMR; Q99MF4; -.
DR   STRING; 10116.ENSRNOP00000020885; -.
DR   GlyCosmos; Q99MF4; 2 sites, No reported glycans.
DR   GlyGen; Q99MF4; 2 sites.
DR   PhosphoSitePlus; Q99MF4; -.
DR   PaxDb; 10116-ENSRNOP00000020885; -.
DR   Ensembl; ENSRNOT00000020885.6; ENSRNOP00000020885.4; ENSRNOG00000015068.6.
DR   Ensembl; ENSRNOT00055029172; ENSRNOP00055023466; ENSRNOG00055017207.
DR   Ensembl; ENSRNOT00060007086; ENSRNOP00060005347; ENSRNOG00060004249.
DR   Ensembl; ENSRNOT00065007004; ENSRNOP00065004817; ENSRNOG00065004830.
DR   GeneID; 245983; -.
DR   KEGG; rno:245983; -.
DR   UCSC; RGD:621332; rat.
DR   AGR; RGD:621332; -.
DR   CTD; 16157; -.
DR   RGD; 621332; Il11ra1.
DR   eggNOG; ENOG502R7G6; Eukaryota.
DR   GeneTree; ENSGT00940000160904; -.
DR   HOGENOM; CLU_047259_0_1_1; -.
DR   InParanoid; Q99MF4; -.
DR   OrthoDB; 5358722at2759; -.
DR   PhylomeDB; Q99MF4; -.
DR   TreeFam; TF331210; -.
DR   Reactome; R-RNO-6788467; IL-6-type cytokine receptor ligand interactions.
DR   PRO; PR:Q99MF4; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000015068; Expressed in pancreas and 20 other cell types or tissues.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0019970; F:interleukin-11 binding; ISO:RGD.
DR   GO; GO:0004921; F:interleukin-11 receptor activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; TAS:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0046697; P:decidualization; ISO:RGD.
DR   GO; GO:0032502; P:developmental process; ISO:RGD.
DR   GO; GO:0007566; P:embryo implantation; IMP:RGD.
DR   GO; GO:0060322; P:head development; ISO:RGD.
DR   GO; GO:0038154; P:interleukin-11-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; ISO:RGD.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0001890; P:placenta development; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003530; Hematopoietin_rcpt_L_F3_CS.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR050379; Type-I_Cytokine_Rcpt.
DR   PANTHER; PTHR23036; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR23036:SF29; INTERLEUKIN-11 RECEPTOR SUBUNIT ALPHA; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS01354; HEMATOPO_REC_L_F3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000250"
FT   CHAIN           24..431
FT                   /note="Interleukin-11 receptor subunit alpha"
FT                   /id="PRO_0000010916"
FT   CHAIN           24..?
FT                   /note="Soluble interleukin-11 receptor subunit alpha"
FT                   /id="PRO_0000450691"
FT   TOPO_DOM        24..371
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        372..392
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        393..431
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..110
FT                   /note="Ig-like C2-type"
FT   DOMAIN          112..219
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          220..317
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          151..170
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          310..360
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          402..431
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           304..308
FT                   /note="WSXWS motif"
FT   COMPBIAS        324..338
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        127
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        194
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        48..94
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        120..130
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        170..180
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   431 AA;  46784 MW;  E086FD6B1688180B CRC64;
     MSSSRSGLTR VLVAVATALV SSSTPCPQAW GPPGVQYGQP GRPVMLCCPG VNAGTPVSWF
     RDGDSRLLQG PDSGLGHRLV LAQVDSRDEG TYVCRTLDGV FGGMVTLKLG SPPARPEVSC
     QAVDYENFSC TWSPGRVSGL PTRYLTSYRK KTLPGAESQR ESPSTGPWPC PQDPLEASRC
     VVHGAEFWSE YRINVTEVNP LGASTCLLDV RLQRILRPDP PQGLRVESVP GYPRRLHASW
     TYPASWRRQP HFLLKFRLQY RPAQHPAWST VEPIGLEELI TDAVAGLPHA VRVSARDFLD
     AGTWSAWSPE AWGTPSTGPL RDEVPDGSRG HEQKLEAAAQ EDSPAPPSPS LQPDPRPLDH
     RDPLEQVAVL ASLGIFSFLG LAVGALALGL WLRLRRSGKD GPQKPGFLAP MIPGDKLPGI
     PNLQRTPENF S
//
